Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Sirtex Medical's SIR-Spheres Y-90 resin microspheres receive FDA approval for hepatocellular carcinoma treatment, marking a breakthrough in targeted radiation therapy.